Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/25 16:15  | 5/8/25  | FULC | Health | Drug | Pharmaceutical Preparations | Tourangeau Greg | MA | O | Principa | S | -3 | 5.06 | 0 | 0 | -3 | 14 | D | ||||||||||||||
7/8/24 08:00  | 7/3/24  | FULC | Health | Drug | Pharmaceutical Preparations | Sapir Alex | MA | DO | See Rema | M.d | 491 | 3.27 | 0 | 150 | 346 | 193 | D | ||||||||||||||
5/9/24 16:10  | 5/7/24  | FULC | Health | Drug | Pharmaceutical Preparations | Tourangeau Greg | MA | O | Principa | S | -2 | 7.76 | 0 | 0 | -2 | 12 | D | ||||||||||||||
3/8/24 18:05  | 3/8/24  | FULC | Health | Drug | Pharmaceutical Preparations | Tourangeau Greg | MA | O | VP,Finan | S | -57 | 11.72 | 0 | -5 | -29 | 12 | D | ||||||||||||||
3/5/24 16:15  | 3/4/24  | FULC | Health | Drug | Pharmaceutical Preparations | Sapir Alex | MA | DO | See Rema | P | 492 | 11.35 | 0 | 43 | New | 43 | D | ||||||||||||||
5/11/23 16:12  | 5/10/23  | FULC | Health | Drug | Pharmaceutical Preparations | Tourangeau Greg | MA | O | Principa | S | -1 | 3.31 | 0 | 0 | -1 | 16 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |